Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
3000 participants
OBSERVATIONAL
2017-01-01
2030-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
CHART Study of Coronary CT Angiography in Coronary Artery Disease
NCT05380622
PRogression of Atheroma Evaluated by CT Angiography and IntraCoronary Imaging tEchniques
NCT06794684
Application of a New X-ray Protective Device in Coronary Interventional Therapy
NCT05088291
Identifying Vulnerable CoronAry PLaqUes With Artificial IntElligence-assisted CT Angiography
NCT06025305
Serial Coronary CTA-based Plaque Progression Detection for Management of Coronary Heart Disease
NCT06843005
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Carotid plaque length
Patients underwent carotid ultrasonography and first coronary angiography simultaneously
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Putuo Hospital, Shanghai University of Traditional Chinese Medicine
UNKNOWN
904th Hospital of the Joint Logistics Support Force of the PLA
OTHER
Gongli Hospital
UNKNOWN
Yueyang Hospital, Shanghai University of Traditional Chinese medicine
UNKNOWN
Changhai Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pan Li
Clinical Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pan Li, PhD
Role: PRINCIPAL_INVESTIGATOR
Changhai Hospital
Jian Na, MD
Role: STUDY_DIRECTOR
Putuo Hospital
Liang Chen, MD
Role: STUDY_DIRECTOR
904th Hospital of the Joint Logistics Support Force of the PLA
Wei Zhang, MD
Role: STUDY_DIRECTOR
Gongli Hospital
Yawei Yang, MD
Role: STUDY_DIRECTOR
Yueyang Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
No. 904 Hospital of the PLA Joint Logistics Support Force
Wuxi, Jiangsu, China
Changhai Hospital
Shanghai, Shanghai Municipality, China
Gongli Hospital
Shanghai, Shanghai Municipality, China
Putuo Hospital
Shanghai, Shanghai Municipality, China
Yueyang Hospital
Shanghai, Shanghai Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CPLi-2017
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.